To see more information:

Dropdown

EE - Estonia
All companies
    All persons

      Search word:

      Field/EMTAK

      TBD PHARMATECH OÜ

      Finances and assets
      The average monthly turnover is 395,190 EUR, the profit margin is 0%, the forecast turnover in 2024 will decrease by 51.5%. As of the property...
      ?
      profile visits
      4,408
      ?
      company tracker
      23

      Turnover prognosis 2024

      6,235,423 â‚¬

      Increased
      by 51.5 % compared to the last year

      Average monthly turnover

      395,190 â‚¬

      Available credit: 94,000 â‚¬
      Settlement dates: 30

      Total profit 2024

      4,820,831 â‚¬

      Retained profits:
      4,872,484 â‚¬ (101 %)
      Net profit:
      -51,653 â‚¬ (-1 %)

      Estimated
      balance 2024

      5,808,943 â‚¬

      Estimated profit
      margin 2024

      0 %
      100 %

      0%

      1 € assets to cover short-term liabilities

      5.98 €

      The main activity of TBD Pharmatech is fine chemistry and synthesis services and small-scale production of active pharmaceutical ingredients. The company's main customers are chemical, pharmaceutical and biotechnology

      Loader

      App Ad

      Scorestorybook Chrome extension

      The Storybook extension tells you which company's website you are currently on and how reliable that company is today. download extension

      See the background of the caller! Storybook App brings you direct contacts for 400,000 Estonian companies and individuals (managers, officials). The data is enriched with solvency and financial information.